secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2022-10-12T23:59:59+00:00
Accession:  0001683168-22-006850
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences issues 850,000 shares to CLS Therapeutics for patent rights
-------------------------------------------------------------------------------

- Issued 850,000 common shares to CLS Therapeutics LLC as consideration for assignment of certain patent rights.
- Transaction closed on October 12, 2022; shares unregistered and sold under Section 4(a)(2) and Regulation D.
- CLS represented itself as an accredited investor; shares restricted and not registered under Securities Act.
- No other securities or cash consideration disclosed; shares issued directly for patent asset acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822006850/0001683168-22-006850-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822006850/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-006850

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer